Have a personal or library account? Click to login

Systemic interleukins levels in community-acquired pneumonia and their association with adverse outcomes

Open Access
|May 2019

References

  1. 1. Antunes G, Evans S, Lordan J, Frew A. Systemic cytokines levels in community-acquired pneumonia and their association with disease severity. Eur Respir J 2002;20:990-995. DOI: 10.1183/09031936.02.0029510210.1183/09031936.02.0029510212412694
  2. 2. Community-Acquired Pneumonia (CAP): Practice Essentials, Overview, Etiology of Community-Acquired Pneumonia [Online]. [2017] [cited 29 April 2018]; Available from: URL: https://emedicine.medscape.com/article/234240-overview
  3. 3. Bordon J, Aliberti S, Fernandez-Botran R, Uriarte S, Rane M, Duvvuri P, et al. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis 2013;17(2):e76-e83. DOI: 10.1016/j.ijid.2012.06.00610.1016/j.ijid.2012.06.00623069683
  4. 4. Fernandez-Botran R, Wiemken T, Kelley R, Peyrani P, Bordon J, Cavallazzi R, et al. Analysis of the local and systemic cytokine response profiles in patients with community-acquired pneumonia. Relationship with disease severity and outcomes. Univ Louisville J Respir 2017;1(3):13-20. DOI: 10.18297/jri/vol1/iss3/5/10.18297/jri/vol1/iss3/5/
  5. 5. Endeman H, Meijvis S, Rijkers G, van Velzen-Blad H, van Moorsel C, Grutters J, et al. Systemic cytokine response in patients with community-acquired pneumonia. Eur Respir J 2011;37(6):1431-1438. DOI: 10.1183/09031936.0007441010.1183/09031936.0007441020884746
  6. 6. Wang RS, Jin HX, Shang SQ, Liu XY, Chen SJ, Jin ZB. Associations of IL-2 and IL-4 Expression and Polymorphisms with the Risks of Mycoplasma pneumoniae Infection and Asthma in Children. Arch Bronconeumol 2015;51(11):571-8. DOI: 10.1016/j.arbres.2014.11.00410.1016/j.arbres.2014.11.00425747600
  7. 7. Paats M, Bergen I, Hanselaar W, Groeninx van Zoelen E, Hoogsteden H, Hendriks R, et al. Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia. Eur Respir J 2013;41(6):1378-85. DOI: 10.1183/09031936.0006011210.1183/09031936.0006011223258791
  8. 8. Lorè N, Bragonzi A, Cigana C. The IL-17A/IL-17RA axis in pulmonary defence and immunopathology. Cytokine Growth Factor Rev 2016;30:19-27. DOI: 10.1016/j.cytogfr.2016.03.00910.1016/j.cytogfr.2016.03.00927033174
  9. 9. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Dean NC, Whitney CG, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis 2007;44:S27-S72. DOI: 10.1086/51115910.1086/511159710799717278083
  10. 10. Eldaboosy SA, Halima KM, Shaarawy AT, Kanany HM, Elgamal EM, El-Gendi AA, et al. Comparison between CURB-65, PSI, and SIPF scores as predictors of ICU admission and mortality in community-acquired pneumonia. The egyptian journal of critical care medicine 2015;3(2):37-44. DOI: 10.1016/j.ejccm.2015.10.00110.1016/j.ejccm.2015.10.001
  11. 11. [Online]. 2018 [cited 26 July 2018]. Available from: URL: https://lifeinthefastlane.com/wp-content/uploads/2010/07/etg-smartcop.
  12. 12. Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W, et al. Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis. Chest 1992;101(6):1644-1655. DOI: 10.1378/chest.101.6.164410.1378/chest.101.6.16441303622
  13. 13. Gutiérrez F, Masiá M, Mirete C, Soldán B, Carlos Rodríguez J, Padilla S, et al. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect 2006;53(3):166-174. DOI: 10.1016/j.jinf.2005.11.00610.1016/j.jinf.2005.11.00616375972
  14. 14. Rozenbaum M, Mangen M, Huijts S, van der Werf T, Postma M. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis. Vaccine 2015;33(28):3193-9. DOI: 10.1016/j.vaccine.2015.05.00110.1016/j.vaccine.2015.05.00125981488
  15. 15. Garau J, Baquero F, Pérez-Trallero E, Pérez J, Martín-Sánchez A, García-Rey C, et al. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect 2008;14(4):322-329. DOI: 10.1111/j.14690691.2007.01915.x10.1111/j.14690691.2007.01915.x
  16. 16. Bacci M, Leme R, Zing N, Murad N, Adami F, Hinnig P, et al. IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients. Braz J Med Biol Res 2015;48(5):427-432. DOI: 10.1590/1414-431X2014440210.1590/1414-431X20144402444566625714883
  17. 17. Puren A, Feldman C, Savage N, Becker P, Smith C. Patterns of Cytokine Expression in Community-Acquired Pneumonia. Chest 1995;107(5):1342-9. DOI: 10.1378/chest.107.5.134210.1378/chest.107.5.13427750329
  18. 18. Holub M, Lawrence D, Andersen N, Davidová A, Beran O, Marešová V, et al. Cytokines and Chemokines as Biomarkers of Community-Acquired Bacterial Infection. Mediators Inflamm 2013;2013:1-7. DOI: 10.1155/2013/19014510.1155/2013/190145365218923690657
  19. 19. Christ-Crain M, Opal S. Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care 2010;14(1):203. DOI: 10.1186/cc815510.1186/cc8155287548020236471
  20. 20. Vasconcellos Â, Clarêncio J, Andrade D, Cardoso MA, Barral A, Nascimento-Carvalho CM. Systemic cytokines and chemokines on admission of children hospitalized with community-acquired pneumonia. Cytokine 2018;107:1-8. DOI: 10.1016/j.cyto.2017.11.00510.1016/j.cyto.2017.11.00529158121
  21. 21. Khattab A, El-Mekkawy M, Shehata A, Whdan N. Clinical study of serum interleukin-6 in children with community-acquired pneumonia. Gaz Egypt Paediatr Assoc 2018;66(2):43-48. DOI: 10.1016/j.epag.2018.03.00310.1016/j.epag.2018.03.003
  22. 22. Chai R, Liu B, Qi F. The significance of the levels of IL-4, IL-31 and TLSP in patients with asthma and/or rhinitis. Immunotherapy 2017;9(4):331-337. DOI: 10.2217/imt-2016-013110.2217/imt-2016-013128303765
  23. 23. Giuffrida M, Valero N, Mosquera J, Duran A, Arocha F, Chacín B, et al. Increased Systemic Cytokine/Chemokine Expression in Asthmatic and Non-asthmatic Patients with Bacterial, Viral or Mixed Lung Infection. Scand J Immunol 2017;85(4):280-290. DOI: 10.1111/sji.1253210.1111/sji.12532716957028168862
  24. 24. Medjo B, Atanaskovic-Markovic M, Nikolic D, Radic S, Lazarevic I, Cirkovic I, et al. Increased Serum Interleukin-10 but not Interleukin-4 Level in Children with Mycoplasma pneumonia pneumonia. J Trop Pediatr 2016;63(4):1-7.
  25. 25. Xu X, Li X, Liu J, Wu L, Chen Z. Serum cytokine profile contributes to discriminating M. pneumoniae pneumonia in children. Cytokine 2016;86:73-78. DOI: 10.1016/j.cyto.2016.07.01810.1016/j.cyto.2016.07.01827475111
  26. 26. Chaudhry H, Zhou J, Zhong Y, Ali MM, McGuire F, Nagarkatti P, et al. Role of cytokines as a double-edged sword in sepsis. In Vivo 2015;27(6):669-84.
  27. 27. Kurata S, Osaki T, Yonezawa H, Arae K, Taguchi H, Kamiya S. Role IL-17A and IL-10 in the antigen induced inflammation model by Mycoplasma pneumoniae. BMC Microbiol 2014;14(1): 156. DOI: 10.1186/1471-2180-14-15610.1186/1471-2180-14-156407413924928272
  28. 28. Paats M, Bergen I, Hanselaar W, van Zoelen E, Verbrugh H, Hoogsteden H, et al. T helper 17 cells are involved in the local and systemic inflammatory response in community-acquired pneumonia. Thorax 2013;68(5):468-474. DOI: 10.1136/thoraxjnl-2012-20216810.1136/thoraxjnl-2012-20216823315492
  29. 29. Higa F, Haroon A, Iha Y, Tasato D, Nakamura H, Kinjo T, et al. Interleukin-17A in Legionella pneumonia: A Retrospective Study. Jpn J Infect Dis 2015;68(2):148-150. DOI: 10.7883/yoken.JJID.2014.17110.7883/yoken.JJID.2014.17125672354
  30. 30. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy MD, Fine J, et al. Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007;167(15):1655-63. DOI: 10.1001/archinte.167.15.165510.1001/archinte.167.15.1655449565217698689
  31. 31. Marti C, Garin N, Grosgurin O, Poncet A, Combescure C, Carballo S, et al. Prediction of severe community-acquired pneumonia : a systematic review and meta-analysis. Crit Care 2012;16(4):R141. DOI: 10.1186/cc1144710.1186/cc11447358072722839689
DOI: https://doi.org/10.2478/rrlm-2019-0020 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 189 - 198
Submitted on: Dec 4, 2018
Accepted on: Mar 3, 2019
Published on: May 2, 2019
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2019 Raluca Elena Tripon, Ioana Berindan Neagoe, Livia Budisan, Tudor Lucian Pop, Victor Cristea, Liana Maria Stanca, Mihaela Sorina Lupse, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.